• Jobs
  • About Us
  • Where to meet us
  • Privacy policy
office@dada.nl | + 31 24 373 03 09
DADA
  • Home
  • Services
    • Regulatory affairs
    • Pharmaceutical development
    • Pharmacovigilance
    • Pharmaceutical Safety and Efficacy (PSE)
    • Market Access
    • Partners
  • News
  • Our team
  • Contact
  • ADOH
  • Search
  • Menu Menu

Archive for category: Pharmaceutical Safety and Efficacy (PSE)

You are here: Home1 / Services2 / Pharmaceutical Safety and Efficacy (PSE)

Phase 1 Environmental Risk Assessment (ERA)

October 20, 2020/in Pharmaceutical Safety and Efficacy (PSE)/by Roy Jacobs
Read more
https://www.dada.nl/wp-content/uploads/2017/11/DADA-logo_RGB_website-221x300.png 0 0 Roy Jacobs https://www.dada.nl/wp-content/uploads/2017/11/DADA-logo_RGB_website-221x300.png Roy Jacobs2020-10-20 14:33:172020-10-20 14:33:19Phase 1 Environmental Risk Assessment (ERA)

Quantitative Structure-Activity Relationship (QSAR) assessment according ICH-M7

October 20, 2020/in Pharmaceutical Safety and Efficacy (PSE)/by Roy Jacobs
Read more
https://www.dada.nl/wp-content/uploads/2017/11/DADA-logo_RGB_website-221x300.png 0 0 Roy Jacobs https://www.dada.nl/wp-content/uploads/2017/11/DADA-logo_RGB_website-221x300.png Roy Jacobs2020-10-20 14:26:512020-10-20 14:26:53Quantitative Structure-Activity Relationship (QSAR) assessment according ICH-M7

Early Access programs

October 20, 2020/in Pharmaceutical Safety and Efficacy (PSE), Regulatory affairs/by Roy Jacobs
Read more
https://www.dada.nl/wp-content/uploads/2017/11/DADA-logo_RGB_website-221x300.png 0 0 Roy Jacobs https://www.dada.nl/wp-content/uploads/2017/11/DADA-logo_RGB_website-221x300.png Roy Jacobs2020-10-20 14:16:542021-01-12 12:36:56Early Access programs

Health based exposure limits (HBEL)

October 20, 2020/in Pharmaceutical Safety and Efficacy (PSE), Regulatory affairs/by Roy Jacobs
Read more
https://www.dada.nl/wp-content/uploads/2017/11/DADA-logo_RGB_website-221x300.png 0 0 Roy Jacobs https://www.dada.nl/wp-content/uploads/2017/11/DADA-logo_RGB_website-221x300.png Roy Jacobs2020-10-20 14:10:542020-10-20 14:10:56Health based exposure limits (HBEL)

Clinical and non-clinical sections of the registration dossier

January 1, 2000/in Pharmaceutical Safety and Efficacy (PSE)/by Dave Jacobs
Read more
https://www.dada.nl/wp-content/uploads/2017/11/DADA-logo_RGB_website-221x300.png 0 0 Dave Jacobs https://www.dada.nl/wp-content/uploads/2017/11/DADA-logo_RGB_website-221x300.png Dave Jacobs2000-01-01 14:26:432019-08-29 13:22:15Clinical and non-clinical sections of the registration dossier

CRO selection and auditing

January 1, 2000/in Pharmaceutical Safety and Efficacy (PSE)/by Dave Jacobs
Read more
https://www.dada.nl/wp-content/uploads/2017/11/DADA-logo_RGB_website-221x300.png 0 0 Dave Jacobs https://www.dada.nl/wp-content/uploads/2017/11/DADA-logo_RGB_website-221x300.png Dave Jacobs2000-01-01 14:19:422021-01-12 14:11:30CRO selection and auditing

Clinical study related documents

January 1, 2000/in Pharmaceutical Safety and Efficacy (PSE)/by Dave Jacobs
Read more
https://www.dada.nl/wp-content/uploads/2017/11/DADA-logo_RGB_website-221x300.png 0 0 Dave Jacobs https://www.dada.nl/wp-content/uploads/2017/11/DADA-logo_RGB_website-221x300.png Dave Jacobs2000-01-01 14:15:542019-08-29 13:39:01Clinical study related documents

Advise on study designs (PK, PD, clinical and PASS)

January 1, 2000/in Pharmaceutical Safety and Efficacy (PSE)/by Dave Jacobs
Read more
https://www.dada.nl/wp-content/uploads/2017/11/DADA-logo_RGB_website-221x300.png 0 0 Dave Jacobs https://www.dada.nl/wp-content/uploads/2017/11/DADA-logo_RGB_website-221x300.png Dave Jacobs2000-01-01 02:06:572021-01-12 17:15:05Advise on study designs (PK, PD, clinical and PASS)

Medical Review

January 1, 2000/in Pharmaceutical Safety and Efficacy (PSE)/by Dave Jacobs
Read more
https://www.dada.nl/wp-content/uploads/2017/11/DADA-logo_RGB_website-221x300.png 0 0 Dave Jacobs https://www.dada.nl/wp-content/uploads/2017/11/DADA-logo_RGB_website-221x300.png Dave Jacobs2000-01-01 02:03:142018-01-08 11:04:11Medical Review

Scientific advice

January 1, 2000/in Pharmaceutical Safety and Efficacy (PSE), Regulatory affairs/by Dave Jacobs
Read more
https://www.dada.nl/wp-content/uploads/2017/11/DADA-logo_RGB_website-221x300.png 0 0 Dave Jacobs https://www.dada.nl/wp-content/uploads/2017/11/DADA-logo_RGB_website-221x300.png Dave Jacobs2000-01-01 02:01:062021-01-12 12:54:39Scientific advice
Page 1 of 212

Latest news

  • DADA wenst u prettige feestdagen en een overtreffend 2021December 21, 2020 - 10:54 am
  • Is DADA “fit for the future”?June 26, 2020 - 3:29 pm
  • The two big events affecting our livesJune 10, 2020 - 2:58 pm

Archives

  • December 2020
  • November 2020
  • October 2020
  • June 2020
  • May 2020
  • March 2020
  • January 2000

DADA CONSULTANCY

DADA Consultancy is a highly specialised and independent consultancy agency in international regulatory affairs of human and veterinary medicinal products.

 

CATEGORIES

  • Blogs
  • Market Access
  • Networks
  • News
  • Pharmaceutical development
  • Pharmaceutical Safety and Efficacy (PSE)
  • Pharmacovigilance
  • Regulatory affairs
  • Uncategorized

BUSINESS HOURS

Our customer support is available from 9am to 5pm: +31 24 373 03 09

Monday-Friday: 9am to 5pm
Saturday: Closed
Sunday: Closed

© Copyright - DADA 2017 - gerealiseerd door RMIC.
  • LinkedIn
  • Jobs
  • About Us
  • Where to meet us
  • Privacy policy
Scroll to top

This site uses functional and analytical cookies. No marketing cookies are placed.

OKPrivacy policy

Cookie and Privacy Settings



How we use cookies

We may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.

Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to deliver the website, refuseing them will have impact how our site functions. You always can block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.

We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.

We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.

Google Analytics Cookies

These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.

If you do not want that we track your visit to our site you can disable tracking in your browser here:

Other external services

We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.

Google Webfont Settings:

Google Map Settings:

Google reCaptcha Settings:

Vimeo and Youtube video embeds:

Other cookies

The following cookies are also needed - You can choose if you want to allow them:

Privacy Policy

You can read about our cookies and privacy settings in detail on our Privacy Policy Page.

Our Privacy Statement
Accept settingsHide notification only